Togioka, Brandon M. http://orcid.org/0000-0002-8285-7811
Schenning, Katie J.
Article History
Accepted: 18 July 2022
First Online: 8 August 2022
Declarations
:
: Support provided in part by department sources within Oregon Health & Science University.
: Brandon Togioka has received two investigator-initiated research grants from Merck & Co., the company that owns and sells ugammadex. The opinions expressed in this article are those of the authors and do not necessarily reflect those of Merck & Co. Katie Schenning declares no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: BT: This author helped with manuscript design, literature review, summary of data, drafting and critically revising the manuscript. KS: This author helped with manuscript design, literature review, summary of data, drafting and critically revising the manuscript.